QNCX Stock Analysis: Buy, Sell, or Hold?
QNCX - Quince Therapeutics, Inc. Common Stock
$19.29
2.04 (11.83%)
▲
5d:
+10.23%
30d:
+1936.96%
90d:
+1268.09%
WAIT
LOW Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 10, 2026
25d
Get Alerted When QNCX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: QNCX is 25.1% above its trading range ($15.42). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: QNCX is 25.1% above its trading range ($15.42). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: QNCX is currently trading at $19.29, which is considered extended relative to its 30-day fair value range of $-0.76 to $15.42.
Technical Outlook: Technically, QNCX is showing sideways momentum. The price is approaching resistance at $1.27. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 11.8% recently.
Market Sentiment: QNCX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $83.33 (+332.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, QNCX is showing sideways momentum. The price is approaching resistance at $1.27. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 11.8% recently.
Market Sentiment: QNCX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $83.33 (+332.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-0.76 -
$15.42
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price significantly overextended (+25.1% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+11.8%)
- BULLISH: Trading 332.0% below Wall St target ($83.33)
- WARNING: Recommendation downgraded due to 25.1% overvaluation
Trading Range Analysis
30-Day Trading Range
$-0.76 -
$15.42
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.95
Resistance Level
$1.27
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.65
Wall Street Target
$83.33
(+332.0%)
Share & Embed Analysis
Last updated: July 14, 2026 8:09 PM ET
Data refreshes hourly during market hours. Next update: 9:09 PM
Data refreshes hourly during market hours. Next update: 9:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QNCX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$258 | 64 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 61 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 61 BUY |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 55 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 59 HOLD |
